Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azathioprine added to corticosteroids for PAN, microscopic polyangiitis, or eosinophilic granulomatosis with polyangiitis without poor-prognosis factors
2007-003690-11Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in polyarteritis nodosa (PAN), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA) comparing Azathioprine plus conventional corticosteroid therapy with Placebo plus conventional corticosteroid therapy (2 arms). Primary endpoint: Complete remission. Started Aug 2010; status: active.
02
Drugs
azathioprine
03
Conditions
polyarteritis nodosa (PAN)microscopic polyangiitis (MPA)eosinophilic granulomatosis with polyangiitis (EGPA)
Beyond the preview
Go deeper on 2007-003690-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003690-11.